[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey
Authors:
- Jeih-San LiowJLJeih-San Liow
- Cheryl L. MorseCMCheryl L. Morse
- Shuiyu LuShuiyu Lu
- Michael FranklandMFMichael Frankland
- George L. TyeGTGeorge L. Tye
- Sami S. ZoghbiSZSami S. Zoghbi
- Robert L. GladdingRGRobert L. Gladding
- Anver B. ShaikAnver B. Shaik
- Robert B. InnisRIRobert B. Innis
- Amy H. NewmanANAmy H. Newman
- Victor W. PikeVPVictor W. Pike
Open Access
Abstract
Selective high-affinity antagonists for the dopamine D3 receptor (D3R) are sought for treating substance use disorders. Positron emission tomography (PET) with an effective D3R radioligand could be a useful tool for the development of such therapeutics by elucidating pharmacological specificity and target engagement in vivo. Currently, a D3R-selective radioligand does not exist. The D3R ligand, N-(4-(4-(3-chloro-2-methoxyphenyl)piperazin-1-yl)butyl)-1H-indole-2-carboxamide (BAK4-51, 1), has attractive properties for PET radioligand development, including full antagonist activity, very high D3R affinity, D3R selectivity, and moderate lipophilicity. We labeled 1 with the positron-emitter carbon-11 (t1/2 = 20.4 min) in the methoxy group for evaluation as a radioligand in animals with PET. However, [11C]1 was found to be an avid substrate for brain efflux transporters and lacked D3R-specific signal in rodent and monkey brain in vivo.Keywords
Funding Information
- National Institutes of Health (ZIA-MH002793, ZIA-MH002795, ZIA-DA000424)
This publication has 55 references indexed in Scilit:
- [11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoproteinEJNMMI Research, 2012
- Endogenous dopamine (DA) competes with the binding of a radiolabeled D3receptor partial agonist in vivo: A positron emission tomography studySynapse, 2010
- Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective AntagonistScience, 2010
- The “Specific” P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)ACS Chemical Neuroscience, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety AttributesACS Chemical Neuroscience, 2010
- [3H]4‐(dimethylamino)‐N‐(4‐(4‐(2‐methoxyphenyl)piperazin‐1‐yl) butyl)benzamide: A selective radioligand for dopamine D3receptors. II. Quantitative analysis of dopamine D3and D2receptor density ratio in the caudate‐putamenSynapse, 2010
- Current perspectives on selective dopamine D3receptor antagonists as pharmacotherapeutics for addictions and related disordersAnnals of the New York Academy of Sciences, 2010
- Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligandNeuroImage, 2009
- Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide — a potential radiotracer for D3 receptor imaging with PETNuclear Medicine and Biology, 2006